Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
About this item
Full title
Author / Creator
Publisher
London: The Fellowship of Postgraduate Medicine
Journal title
Language
English
Formats
Publication information
Publisher
London: The Fellowship of Postgraduate Medicine
Subjects
More information
Scope and Contents
Contents
The last 20 years have witnessed dramatic reductions in cardiovascular risk using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (“statins”) to lower levels of low-density lipoprotein cholesterol (LDL-C). Using this approach one can achieve a reduction in the risk of major cardiovascular events of 21% for every 1 mmol/l (39 mg/dl) decre...
Alternative Titles
Full title
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70736978
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70736978
Other Identifiers
ISSN
0032-5473,1355-6037
E-ISSN
1469-0756,1468-201X
DOI
10.1136/hrt.2007.125401
